$TBLT
Toughbuilt Industries, Inc

2023 Q4 Form 10-Q Financial Statement

#000157587223001805 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $20.63M
YoY Change -31.79%
Cost Of Revenue $15.72M
YoY Change -29.61%
Gross Profit $4.913M
YoY Change -37.95%
Gross Profit Margin 23.81%
Selling, General & Admin $12.57M
YoY Change -14.34%
% of Gross Profit 255.9%
Research & Development $2.916M
YoY Change 4.84%
% of Gross Profit 59.36%
Depreciation & Amortization $1.480M
YoY Change 27.07%
% of Gross Profit 30.12%
Operating Expenses $15.49M
YoY Change -11.28%
Operating Profit -$10.58M
YoY Change 10.85%
Interest Expense $146.9K
YoY Change -99.21%
% of Operating Profit
Other Income/Expense, Net -$3.673M
YoY Change -120.93%
Pretax Income -$14.25M
YoY Change -277.98%
Income Tax
% Of Pretax Income
Net Earnings -$14.25M
YoY Change -277.96%
Net Earnings / Revenue -69.07%
Basic Earnings Per Share -$0.46
Diluted Earnings Per Share -$0.46
COMMON SHARES
Basic Shares Outstanding 36.92M 33.70M
Diluted Shares Outstanding 31.30M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.830M
YoY Change 15.21%
Cash & Equivalents $1.153M $1.834M
Short-Term Investments
Other Short-Term Assets $540.0K
YoY Change -81.13%
Inventory $21.94M $28.07M
Prepaid Expenses
Receivables $10.24M $8.993M
Other Receivables $0.00
Total Short-Term Assets $33.50M $39.44M
YoY Change -44.27% -41.88%
LONG-TERM ASSETS
Property, Plant & Equipment $13.78M $18.90M
YoY Change -21.28% 1.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.165M
YoY Change 28.64%
Total Long-Term Assets $18.29M $25.09M
YoY Change -23.18% 0.2%
TOTAL ASSETS
Total Short-Term Assets $33.50M $39.44M
Total Long-Term Assets $18.29M $25.09M
Total Assets $51.79M $64.53M
YoY Change -38.28% -30.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $46.95M $41.09M
YoY Change 58.25% 41.23%
Accrued Expenses $5.278M $4.462M
YoY Change 75.28% 62.49%
Deferred Revenue
YoY Change
Short-Term Debt $288.6K $707.6K
YoY Change -70.36% -49.12%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $60.12M $53.25M
YoY Change 18.51% 35.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $3.010M
YoY Change -19.17%
Total Long-Term Liabilities $3.010M
YoY Change -19.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.12M $53.25M
Total Long-Term Liabilities $3.010M
Total Liabilities $61.51M $56.26M
YoY Change 13.47% 30.57%
SHAREHOLDERS EQUITY
Retained Earnings -$191.4M -$173.2M
YoY Change 32.0% 42.08%
Common Stock $57.00 $3.691K
YoY Change -95.95% 199.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.721M $8.271M
YoY Change
Total Liabilities & Shareholders Equity $51.79M $64.53M
YoY Change -38.28% -30.53%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$14.25M
YoY Change -277.96%
Depreciation, Depletion And Amortization $1.480M
YoY Change 27.07%
Cash From Operating Activities -$1.960M
YoY Change -88.74%
INVESTING ACTIVITIES
Capital Expenditures $1.060M
YoY Change -119.9%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.060M
YoY Change -80.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.650M
YoY Change -88.05%
NET CHANGE
Cash From Operating Activities -1.960M
Cash From Investing Activities -1.060M
Cash From Financing Activities 2.650M
Net Change In Cash -370.0K
YoY Change -33.28%
FREE CASH FLOW
Cash From Operating Activities -$1.960M
Capital Expenditures $1.060M
Free Cash Flow -$3.020M
YoY Change -74.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001668370
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38739
dei Entity Registrant Name
EntityRegistrantName
TOUGHBUILT INDUSTRIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0820877
dei Entity Address Address Line1
EntityAddressAddressLine1
8669 Research Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
528-3100
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36915222
CY2023Q3 us-gaap Cash
Cash
1834305
CY2022Q4 us-gaap Cash
Cash
2564237
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8992889
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16810659
CY2023Q3 us-gaap Inventory Net
InventoryNet
28070889
CY2022Q4 us-gaap Inventory Net
InventoryNet
40365286
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
543343
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
369792
CY2023Q3 us-gaap Assets Current
AssetsCurrent
39441426
CY2022Q4 us-gaap Assets Current
AssetsCurrent
60109974
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18904135
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17500383
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4021988
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4415859
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2165301
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1890780
CY2023Q3 us-gaap Assets
Assets
64532850
CY2022Q4 us-gaap Assets
Assets
83916996
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
41091115
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
29671272
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4461713
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3010914
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1247062
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
959630
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
707625
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
973583
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5740899
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16116273
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
53248414
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50731672
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3013214
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3477380
CY2023Q3 us-gaap Liabilities
Liabilities
56261628
CY2022Q4 us-gaap Liabilities
Liabilities
54209052
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36915222
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36915222
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14078997
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14078997
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
3691
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1408
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181469690
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
174659589
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173202159
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144953053
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
8271222
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29707944
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64532850
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83916996
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20630207
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30245251
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59722486
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65353651
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15717233
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22328094
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45411269
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49484951
CY2023Q3 us-gaap Gross Profit
GrossProfit
4912974
CY2022Q3 us-gaap Gross Profit
GrossProfit
7917157
us-gaap Gross Profit
GrossProfit
14311217
us-gaap Gross Profit
GrossProfit
15868700
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12572066
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14676135
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42618510
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45106976
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2916349
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2781676
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9357273
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8050481
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
15488815
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
17457811
us-gaap Operating Expenses
OperatingExpenses
51975783
us-gaap Operating Expenses
OperatingExpenses
53157457
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10575441
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9540654
us-gaap Operating Income Loss
OperatingIncomeLoss
-37664566
us-gaap Operating Income Loss
OperatingIncomeLoss
-37288757
CY2023Q3 tblt Warrant Issuance Costs
WarrantIssuanceCosts
186450
CY2022Q3 tblt Warrant Issuance Costs
WarrantIssuanceCosts
969791
tblt Warrant Issuance Costs
WarrantIssuanceCosts
538218
tblt Warrant Issuance Costs
WarrantIssuanceCosts
1415229
CY2023Q3 tblt Change In Fair Value Of Warrant And Preferred Investment Option Liabilities
ChangeInFairValueOfWarrantAndPreferredInvestmentOptionLiabilities
3033537
CY2022Q3 tblt Change In Fair Value Of Warrant And Preferred Investment Option Liabilities
ChangeInFairValueOfWarrantAndPreferredInvestmentOptionLiabilities
19065297
tblt Change In Fair Value Of Warrant And Preferred Investment Option Liabilities
ChangeInFairValueOfWarrantAndPreferredInvestmentOptionLiabilities
17761007
tblt Change In Fair Value Of Warrant And Preferred Investment Option Liabilities
ChangeInFairValueOfWarrantAndPreferredInvestmentOptionLiabilities
23111029
CY2023Q3 tblt Inducement Expense
InducementExpense
6373353
tblt Inducement Expense
InducementExpense
6373353
CY2023Q3 us-gaap Interest Expense
InterestExpense
146867
CY2022Q3 us-gaap Interest Expense
InterestExpense
548422
us-gaap Interest Expense
InterestExpense
1433975
us-gaap Interest Expense
InterestExpense
640603
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3673133
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17547084
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9415461
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21055197
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14248574
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
8006430
us-gaap Net Income Loss
NetIncomeLoss
-28249105
us-gaap Net Income Loss
NetIncomeLoss
-16233560
CY2022Q3 tblt Common Stock Deemed Dividend
CommonStockDeemedDividend
7467200
tblt Common Stock Deemed Dividend
CommonStockDeemedDividend
7467200
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14248574
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
539230
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28249105
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23700760
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.42
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31298034
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10872412
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20663732
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4376175
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.42
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31298034
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19721339
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20663732
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4376175
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57896523
CY2022Q1 tblt Stock Issued During Period Value Adoption Of Lease Guidance
StockIssuedDuringPeriodValueAdoptionOfLeaseGuidance
97310
CY2022Q1 tblt Adjustments To Additional Paid In Capital Preferred Stock Value
AdjustmentsToAdditionalPaidInCapitalPreferredStockValue
1833995
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13101
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12103938
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
47736991
CY2022Q2 tblt Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
1849072
CY2022Q2 tblt Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
6358399
CY2022Q2 tblt Repurchase Of Common Stock Warrants
RepurchaseOfCommonStockWarrants
-2500000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12136051
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13101
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
41321512
CY2022Q3 tblt Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
-1293327
CY2022Q3 tblt Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
9230014
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
539230
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13101
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
49810530
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29707944
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
115139
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8275162
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21547921
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
551833
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113517
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5725370
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16487901
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5824180
CY2023Q3 tblt Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
108244
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
99471
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14248574
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
8271222
us-gaap Net Income Loss
NetIncomeLoss
-28249105
us-gaap Net Income Loss
NetIncomeLoss
-16233560
us-gaap Depreciation
Depreciation
4088358
us-gaap Depreciation
Depreciation
3103204
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2943671
us-gaap Share Based Compensation
ShareBasedCompensation
328127
us-gaap Share Based Compensation
ShareBasedCompensation
39303
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1098831
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
451481
tblt Warrant Issuance Costs
WarrantIssuanceCosts
538218
tblt Warrant Issuance Costs
WarrantIssuanceCosts
1415229
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15806
tblt Increase Decrease In Inducement Expense
IncreaseDecreaseInInducementExpense
-6373353
tblt Repayment Of Short Term Loan Payable In Exchange For New Short Term Loan Payable
RepaymentOfShortTermLoanPayableInExchangeForNewShortTermLoanPayable
1601205
tblt Derecognition Of Warrant Liability Upon Conversion
DerecognitionOfWarrantLiabilityUponConversion
9610346
us-gaap Net Income Loss
NetIncomeLoss
-28200000
tblt Change In Fair Value Of Warrant And Preferred Investment Option Liabilities
ChangeInFairValueOfWarrantAndPreferredInvestmentOptionLiabilities
17761007
tblt Change In Fair Value Of Warrant And Preferred Investment Option Liabilities
ChangeInFairValueOfWarrantAndPreferredInvestmentOptionLiabilities
23111029
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4874099
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5223695
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12294396
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1573602
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
173551
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2075468
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
274520
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
940469
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9240985
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13263112
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1450799
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1037768
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-881694
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-463217
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4109040
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30295137
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3313252
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7113646
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3313252
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7063646
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5978067
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
2500000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6958318
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26606099
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
779795
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1669000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1045753
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
278167
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6692360
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31474999
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-729932
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5883784
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2564237
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7472224
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1834305
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1588440
us-gaap Interest Paid Net
InterestPaidNet
1433976
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
tblt Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
2178858
tblt Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
1392570
tblt Initial Fair Value Of Lease Liability
InitialFairValueOfLeaseLiability
704960
tblt Initial Fair Value Of Lease Liability
InitialFairValueOfLeaseLiability
5140057
tblt Initial Fair Value Of Warrants And Preferred Investment Options
InitialFairValueOfWarrantsAndPreferredInvestmentOptions
9916393
tblt Initial Fair Value Of Warrants And Preferred Investment Options
InitialFairValueOfWarrantsAndPreferredInvestmentOptions
23488442
CY2020Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company effected a 1-for-10 reverse stock split (the “Reverse Split”) of its issued and outstanding common stock
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company effected a 1-for-150 reverse stock split (the “2022 Reverse Split”) of its issued and outstanding common stock
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173200000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4100000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation and recognition of revenue, accounts and factored receivables, valuation of long-lived assets, accrued liabilities, notes payable, going concern assumptions, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</div><br/></div>
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2050917
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2918869
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
138060
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
514615
us-gaap Advertising Expense
AdvertisingExpense
621988
us-gaap Advertising Expense
AdvertisingExpense
2805812
CY2020 tblt Percentage Of Limitations On Net Operating Loss Carryforwards Was Removed According To Cares Act
PercentageOfLimitationsOnNetOperatingLossCarryforwardsWasRemovedAccordingToCaresAct
0.80
CY2019 tblt Percentage Of Limitations On Net Operating Loss Carryforwards Was Removed According To Cares Act
PercentageOfLimitationsOnNetOperatingLossCarryforwardsWasRemovedAccordingToCaresAct
0.80
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14248574
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
539230
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28249105
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23700760
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.42
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31298034
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10872412
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20663732
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4376175
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.42
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31298034
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19721339
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20663732
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4376175
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34142455
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8848827
CY2023Q2 us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
PCS Properties 2, LLC
CY2023Q2 us-gaap Loss Contingency Allegations
LossContingencyAllegations
In the complaint, the Plaintiff is suing the Company for Breach of the Company’s lease agreement, dated December 10, 2021 (the “Lease”), for the real property located at 8687 Research Drive, Suites 100, 150, 250, Irvine, CA 92618 (collectively, the “Premises”).
CY2023Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
124800
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11210501
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7130916
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18904135
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17500383
CY2023Q3 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
1479582
CY2022Q3 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
1164689
us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
4088358
us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
3103204
CY2017Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2017Q1 us-gaap Security Deposit
SecurityDeposit
29297
CY2017Q1 tblt Direct Costs Estimated Percentage
DirectCostsEstimatedPercentage
0.2254
CY2017Q1 us-gaap Lease Cost
LeaseCost
6201
CY2017Q1 tblt Lease Expired During The Period
LeaseExpiredDuringThePeriod
2022-02
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The lease commenced on December 1, 2019 with no rent due until April 1, 2020. From April 1, 2020 through March 31, 2025, base rent is due on the first of each month in the amount of $25,200 escalating annually on December 1st of each year to $29,480 beginning December 1, 2023. The Company paid an initial amount of $68,128 comprising the rent for April 2020
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
375000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4021988
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1247062
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3013214
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4260276
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M2D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
352722
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1481667
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1245379
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1211105
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
333915
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4624788
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
364512
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4260276
us-gaap Payments For Rent
PaymentsForRent
1442730
us-gaap Payments For Rent
PaymentsForRent
691107
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
430839
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
233200
us-gaap Loss Contingency Allegations
LossContingencyAllegations
In the complaint, the 2022 Plaintiff alleged a breach of the applicable 2022 Defendants’ fiduciary duties of loyalty, good faith, and due care owed to us and our shareholders, by negligently, willfully, recklessly and/or intentionally failing to perform their fiduciary duties primarily in connection with our registered direct offering of 2,500 shares of Series F preferred stock and 2,500 shares of Series G preferred stock in February 2022 and subsequent 1-for-150 reverse stock split effected in April 2022.
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-150
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4268
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4268
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
5000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2022Q1 tblt Percentage Of Cashfee Equal To Gross Proceeds
PercentageOfCashfeeEqualToGrossProceeds
0.07
CY2022Q1 tblt Percentage Of Management Fee Equal To Gross Proceeds
PercentageOfManagementFeeEqualToGrossProceeds
0.005
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4205000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
795000
CY2022Q1 tblt Initial Fair Value Of Warrants
InitialFairValueOfWarrants
2646135
CY2022 tblt Warrant Issuance Costs
WarrantIssuanceCosts
275130
CY2022 tblt Warrants Issuance Costs Expensed
WarrantsIssuanceCostsExpensed
170308
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4589108
CY2022Q4 tblt Warrant Issuance Costs
WarrantIssuanceCosts
453537
CY2023Q3 tblt Class Of Warrant Or Right Issued During The Period
ClassOfWarrantOrRightIssuedDuringThePeriod
10619911
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.3201
CY2023Q3 us-gaap Legal Fees
LegalFees
50000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
25000
CY2023Q3 tblt Clearing Fees
ClearingFees
15950
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6319909
CY2023Q3 tblt Warrant Issuance Costs
WarrantIssuanceCosts
296450
tblt Inducement Expense
InducementExpense
6373353
CY2020Q2 tblt Warrants Exercisable Shares Description
WarrantsExercisableSharesDescription
the Company sold 138,000 warrants (each exercisable into 1 share of common stock for a total of 138,000 shares of common stock).
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
121.5
CY2022Q2 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
2500000
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
37.65
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.9
tblt Revenue Recognition Reserve For Sales Returns And Allowances
RevenueRecognitionReserveForSalesReturnsAndAllowances
407246
CY2022 tblt Revenue Recognition Reserve For Sales Returns And Allowances
RevenueRecognitionReserveForSalesReturnsAndAllowances
407246
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1553890
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2314237

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001575872-23-001805-index-headers.html Edgar Link pending
0001575872-23-001805-index.html Edgar Link pending
0001575872-23-001805.txt Edgar Link pending
0001575872-23-001805-xbrl.zip Edgar Link pending
cm454_ex31-1.htm Edgar Link pending
cm454_ex31-2.htm Edgar Link pending
cm454_ex32-1.htm Edgar Link pending
cm454_ex32-2.htm Edgar Link pending
cm454_img01.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tblt-20230930.htm Edgar Link pending
tblt-20230930.xsd Edgar Link pending
tblt-20230930_cal.xml Edgar Link unprocessable
tblt-20230930_def.xml Edgar Link unprocessable
tblt-20230930_lab.xml Edgar Link unprocessable
tblt-20230930_pre.xml Edgar Link unprocessable
tblt-20230930_htm.xml Edgar Link completed